RT Book, Section
A1 Corwin, Howard L.
A1 Napolitano, Lena M.
A2 Schmidt, Gregory A.
A2 Kress, John P.
A2 Douglas, Ivor S.
SR Print(0)
ID 1201807857
T1 Anemia and Red Blood Cell Transfusion in the Critically Ill Patient
T2 Hall, Schmidt and Wood’s Principles of Critical Care, 5<sup>th</sup> Edition
YR 2023
FD 2023
PB McGraw Hill
PP New York, NY
SN 9781264264353
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1201807857
RD 2023/12/07
AB KEY  POINTSAnemia  is  common  in  the  critically  ill  and  is  associated  with  the  use  of  red  blood  cell  (RBC)  transfusions  and  worse  clinical  outcomes.Anemia  management,  independent  of  RBC  transfusion,  is  important.  This  may  include  the  use  of  erythropoiesis-stimulating  agents  and/or  iron.The  risks  of  RBC  transfusions  have  expanded  and  are  well  documented.Little  data  support  efficacy  of  RBC  transfusions  in  many  clinical  situations  in  which  they  are  given.In  general  for  critically  ill  patients,  a  restrictive  strategy  (consider  RBC  transfusion  when  hemoglobin  ≤7  g/dL)  is  recommended.In  patients  with  acute  coronary  syndrome,  consider  RBC  transfusion  when  Hb  ≤8  g/dL.Patient  preferences  and  Patient  Blood  Management  guidelines  should  be  considered  when  considering  blood  transfusion.Anemia  prevention  in  the  ICU  includes  efforts  to  reduce  phlebotomy  and  diagnostic  laboratory  testing,  use  of  pediatric  or  low-volume  sampling  tubes,  and  blood  loss  prevention.